The electromagnetic fields produced by incubators alter newborns’ heart rates, says a small study published in the Fetal and Neonatal Edition of Archives of Disease in Childhood.

The research team assessed the variability in the heart rate of 43 newborn babies, none of whom was critically ill or premature.

The risks of developing Alzheimer’s disease differ between the sexes, with stroke in men, and depression in women, critical factors, according to research published in the Journal of Neurology Neurosurgery and Psychiatry.

French researchers based their findings on almost 7000 people over the age of 65, drawn from the general population in three French cities. None had dementia, but around four out of 10 were deemed to have mildly impaired mental agility (mild cognitive impairment) at the start of the study.

Their progress was assessed two and four years later. In all, just over 6.5% of those deemed to be cognitively impaired developed dementia over the next four years. In just over half, no change was seen. Just over one in three reverted to normal levels of cognitive agility.

ST ALBANS, England, May 1 /PRNewswire/ --

On the 1st of May 2008, UK charity, the Psoriasis and Psoriatic Arthritis Alliance (PAPAA) is launching its new website http://www.papaa.org under the banner of The Principal Source of Information for Psoriasis and Psoriatic Arthritis. PAPAA is providing an up-to-date resource that will give people with the latest information about the condition along with what treatments are available and useful articles.

PAPAA is independently funded and doesn't receive financial support from the commercial or pharmaceutical industry. The site is managed by PAPAA with real input from people with or affected by psoriasis and psoriatic arthritis.

SAN FRANCISCO, April 30 /PRNewswire/ --

Jadworks announces the general release of its new IBM Lotus Domino based Intranet Application for large enterprises (Jadworks Suite). The Jadworks Suite enables IT departments and end-users to easily build secure intranets and collaborative applications including document management systems, human resources portals, project management tracking, marketing communications, and other information intensive applications. Key system functions and capabilities include discussion blogs, self-service posting of internal announcements, employee directory and phone list builder, managers toolkit, bulletin board, fast search, email notification, and electronic signature.

The biggest ever science experiment, the Large Hadron Collider, should be operational this summer.  Three years behind schedule and 30% over budget, the $8.7 billion LHC will collide protons together and lead ions next year, at colossal energies never before attempted.  Don't hold your breath.  Rudiger Schmidt at CERN, near Geneva, says,"The LHC is a frightening complex accelerator."  A lot could still go wrong even before startup. 

On the engineering side, most of the equipment custom designed and built, problems also are complex.  One particular sore spot was a big triplet superconducting magnet from Fermilab, that exploded 13 months ago during a pressure test, releasing helium coolant.  A design flaw had to be fixed in all 8 magnets, and finally, yesterday, one was successfully tested, applauded by a team of 50 physicists, engineers and technicians. There are another 1232 dipoles of  15 meter length, 400 5-7 meter focusing quadrupoles, and 5,000 corrector magnets to keep the hadrons, protons or ions, in the 27 kilometer main ring.

BAAR, Switzerland, April 30 /PRNewswire/ -- Manas Petroleum Corp., a Baar, Switzerland based company, today announces its wholly owned subsidiary, Manas Energia limitada Chile (Manas) and Improved Petroleum Recovery Tranquillo Chile (IPR), has signed on April 30th a "Special Operating Contract" (CEOP) with the Chilean government in Santiago de Chile. The televised ceremony was chaired by the Chilean President Mrs. Michelle Bachelet. Under Chilean law the council of ministers must ratify the contract. This formality is expected to be completed during Q2 2008.

A nationwide consortium has completed the first sequence-based map of structural variations in the human genome, giving scientists an overall picture of the large-scale differences in DNA between individuals. The project gives researchers a guide for further research into these structural differences, which are believed to play an important role in human health and disease.

The project involved sequencing the genomes of eight people from a diverse set of ethnic backgrounds: four individuals of African descent, two of Asian descent, and two of European background.

The researchers created what's called a clone map, taking multiple copies of each of the eight genomes and breaking them into numerous segments of about 40,000 base pairs, which they then fit back together based on the human reference genome. They searched for structural differences that ranged in size from a few thousand to a few million base pairs. Base pairs are one of the basic units of information on the human genome.

FALLS CHURCH, Virginia, April 30 /PRNewswire/ --

- Contract Expands Companies' Global Relationship

Computer Sciences Corporation (NYSE: CSC) today announced that it has signed an information technology (IT) desktop services outsourcing contract expanding the scope of services CSC provides to Zurich Financial Services Group (Zurich), a world-leading, insurance-based financial services provider. The new agreement has a six-year base period at an estimated value of US$399 million with a two-year extension option.

BASINGSTOKE, England, April 30 /PRNewswire/ --

- Applications and content from Motorola ecosystem partners help create the most compelling mobile experience for MOTO Z10 users

Motorola, Inc. (NYSE: MOT), today announced an array of applications from ecosystem partners available now on the MOTO Z10 mobile device, taking the mobile experience for consumers to a whole new level.

HALIFAX, England and NOVA SCOTIA, Canada, April 30 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax(TM) platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax(TM) concept.

"The results from our preclinical studies demonstrate that DepoVax(TM) is highly effective with a single dose," remarked Marc Mansour, vice president of research and development at IVT. "DepoVax(TM) is superior to conventional vaccine formulations in its ability to raise strong cellular and humoral immune responses to a variety of antigens, a hallmark of IVT's vaccine formulations."